Literature DB >> 15475512

Neural regulation of glucagon-like peptide-1 secretion in pigs.

Lene Hansen1, Sarah Lampert, Hitoshi Mineo, Jens J Holst.   

Abstract

Glucagon-like peptide (GLP)-1 is secreted rapidly from the intestine postprandially. We therefore investigated its possible neural regulation. With the use of isolated perfused porcine ileum, GLP-1 secretion was measured in response to electrical stimulation of the mixed, perivascular nerve supply and infusions of neuroactive agents alone and in combination with different blocking agents. Electrical nerve stimulation inhibited GLP-1 secretion, an effect abolished by phentolamine. Norepinephrine inhibited secretion, and phentolamine abolished this effect. GLP-1 secretion was stimulated by isoproterenol (abolished by propranolol). Acetylcholine stimulated GLP-1 secretion, and atropine blocked this effect. Dimethylphenylpiperazine stimulated GLP-1 secretion. In chloralose-anesthetized pigs, however, electrical stimulation of the vagal trunks at the level of the diaphragm had no effect on GLP-1 or GLP-2 and weak effects on glucose-dependent insulinotropic peptide and somatostatin secretion, although this elicited a marked atropine-resistant release of the neuropeptide vasoactive intestinal polypeptide to the portal circulation. Thus GLP-1 secretion is inhibited by the sympathetic nerves to the gut and may be stimulated by intrinsic cholinergic nerves, whereas the extrinsic vagal supply has no effect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15475512     DOI: 10.1152/ajpendo.00197.2004

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  25 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

Review 2.  The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes.

Authors:  Randy J Seeley; Adam P Chambers; Darleen A Sandoval
Journal:  Cell Metab       Date:  2015-02-05       Impact factor: 27.287

Review 3.  Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

Authors:  M A Nauck; I Vardarli; C F Deacon; J J Holst; J J Meier
Journal:  Diabetologia       Date:  2010-09-25       Impact factor: 10.122

Review 4.  Targeting beta-cell mass in type 2 diabetes: promise and limitations of new drugs based on incretins.

Authors:  Marzieh Salehi; Benedikt A Aulinger; David A D'Alessio
Journal:  Endocr Rev       Date:  2008-02-21       Impact factor: 19.871

5.  Putting the Hindgut Hypothesis to the Test in a Diabetic Zucker Rat Model.

Authors:  Claudia Laessle; Ke Jin; Gabriel J Seifert; Sylvia Timme-Bronsert; Stefan Fichtner-Feigl; Goran Marjanovic; Jodok Matthias Fink
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

6.  Effect of portal glucose sensing on incretin hormone secretion in a canine model.

Authors:  Dale S Edgerton; Guillaume Kraft; Marta S Smith; Lindsey M Moore; Ben Farmer; Melanie Scott; Mary C Moore; Michael A Nauck; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-05-21       Impact factor: 4.310

7.  In vivo, ex vivo and in vitro evidence for atropine-mediated attenuation of glucagon-like peptide-1 secretion: findings from a systematic review.

Authors:  Devarajan Rathish; Suneth Agampodi; Channa Jayasumana
Journal:  Environ Sci Pollut Res Int       Date:  2019-08-24       Impact factor: 4.223

Review 8.  Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.

Authors:  Per T Sangild; Denise M Ney; David L Sigalet; Andreas Vegge; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-23       Impact factor: 4.052

9.  Effect of tasteless calorie-free gum chewing before meal on postprandial plasma glucose, insulin, glucagon, and gastrointestinal hormones in Japanese men without diagnosed glucose metabolism disorder: a pilot randomized crossover trial.

Authors:  Mitsuyoshi Takahara; Masahiro Fukuda; Yuji Matsuzawa; Iichiro Shimomura
Journal:  Diabetol Int       Date:  2020-04-11

10.  Chylomicron formation and secretion is required for lipid-stimulated release of incretins GLP-1 and GIP.

Authors:  Wendell J Lu; Qing Yang; Li Yang; Dana Lee; David D'Alessio; Patrick Tso
Journal:  Lipids       Date:  2012-06       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.